Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonia Resag

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|June 1, 2023
Prognostic impact of the post-treatment T cell composition and spatial organization in soft tissue sarcoma patients treated with neoadjuvant hyperthermic radio(chemo)therapyLuise Rupp, Antonia Resag, Vlatko Potkrajcic, et al.
Frontiers in Immunology|June 28, 2024
Type I conventional dendritic cells and CD8<sup>+</sup> T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patientsJohanna Kirchner, Ioana Plesca, Rebecca Rothe, et al.
Cancers|October 14, 2022
The Immune Contexture of Liposarcoma and Its Clinical ImplicationsAntonia Resag, Giulia Toffanin, Iva Benešová, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 19, 2026
Targeting Langerhans cells using a modular mannosylated nucleic acid-based vaccine platformSimon Christian Vinther, Antonia Resag, Karina Thao Thu Le, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanomaFlorian Hornsteiner, Janine Vierthaler, Helen Strandt, et al.
Journal for Immunotherapy of Cancer|June 30, 2026
Metabolic inhibition of glutamate-cysteine ligase increases dendritic cell-mediated antitumor immunity in melanomaSophie Marie Dieckmann, Christoph H Tripp, Helen Strandt, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|June 1, 2023
Prognostic impact of the post-treatment T cell composition and spatial organization in soft tissue sarcoma patients treated with neoadjuvant hyperthermic radio(chemo)therapyLuise Rupp, Antonia Resag, Vlatko Potkrajcic, et al.
Frontiers in Immunology|June 28, 2024
Type I conventional dendritic cells and CD8<sup>+</sup> T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patientsJohanna Kirchner, Ioana Plesca, Rebecca Rothe, et al.
Cancers|October 14, 2022
The Immune Contexture of Liposarcoma and Its Clinical ImplicationsAntonia Resag, Giulia Toffanin, Iva Benešová, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 19, 2026
Targeting Langerhans cells using a modular mannosylated nucleic acid-based vaccine platformSimon Christian Vinther, Antonia Resag, Karina Thao Thu Le, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanomaFlorian Hornsteiner, Janine Vierthaler, Helen Strandt, et al.
Journal for Immunotherapy of Cancer|June 30, 2026
Metabolic inhibition of glutamate-cysteine ligase increases dendritic cell-mediated antitumor immunity in melanomaSophie Marie Dieckmann, Christoph H Tripp, Helen Strandt, et al.
Pageof 1